Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Wolfgang W Leitner

Showing results (1-10 of 63) with videos related to

Pageof 7
Sort By:
Expert Opinion on Biological Therapy|April 30, 2003
Myth, menace or medical blessing? The clinical potential and problems of genetic vaccinesWolfgang W Leitner
Immunotherapy|July 14, 2012
Vaccine adjuvants: is the pipeline clogged?Wolfgang W Leitner
Expert Opinion on Biological Therapy|July 2, 2003
DNA vaccines for non-infectious diseases: new treatments for tumour and allergyWolfgang W Leitner, Josef Thalhamer
The Journal of Clinical Investigation|July 4, 2003
DNA vaccines and apoptosis: to kill or not to kill?Wolfgang W Leitner, Nicholas P Restifo
Vaccine|November 16, 2010
Innate immunity in HIV infection and implications for vaccine design: a summary of the workshop held at the National Institute of Allergy and Infectious Diseases, Bethesda on February 25-26, 2010Geetha P Bansal, Wolfgang W Leitner
Current Opinion in Virology|May 6, 2026
Next-Generation vaccine adjuvants: NIAID perspective on mechanistic insights and emerging strategiesHalonna R Kelly, Wolfgang W Leitner
Vaccines|September 8, 2015
Adjuvants in the Driver's Seat: How Magnitude, Type, Fine Specificity and Longevity of Immune Responses Are Driven by Distinct Classes of Immune PotentiatorsElke S Bergmann-Leitner, Wolfgang W Leitner
Methods in Molecular Biology (Clifton, N.J.)|October 10, 2015
Vaccination Using Gene-Gun TechnologyElke S Bergmann-Leitner, Wolfgang W Leitner
Therapeutic Delivery|July 26, 2013
Improving DNA vaccines against malaria: could immunization by gene gun be the answer?Elke S Bergmann-Leitner, Wolfgang W Leitner
Microbes and Infection|April 7, 2004
Danger, death and DNA vaccinesElke S Bergmann-Leitner, Wolfgang W Leitner
Pageof 7

Showing results (1-10 of 63) with videos related to

Sort By:
Pageof 7
Expert Opinion on Biological Therapy|April 30, 2003
Myth, menace or medical blessing? The clinical potential and problems of genetic vaccinesWolfgang W Leitner
Immunotherapy|July 14, 2012
Vaccine adjuvants: is the pipeline clogged?Wolfgang W Leitner
Expert Opinion on Biological Therapy|July 2, 2003
DNA vaccines for non-infectious diseases: new treatments for tumour and allergyWolfgang W Leitner, Josef Thalhamer
The Journal of Clinical Investigation|July 4, 2003
DNA vaccines and apoptosis: to kill or not to kill?Wolfgang W Leitner, Nicholas P Restifo
Vaccine|November 16, 2010
Innate immunity in HIV infection and implications for vaccine design: a summary of the workshop held at the National Institute of Allergy and Infectious Diseases, Bethesda on February 25-26, 2010Geetha P Bansal, Wolfgang W Leitner
Current Opinion in Virology|May 6, 2026
Next-Generation vaccine adjuvants: NIAID perspective on mechanistic insights and emerging strategiesHalonna R Kelly, Wolfgang W Leitner
Vaccines|September 8, 2015
Adjuvants in the Driver's Seat: How Magnitude, Type, Fine Specificity and Longevity of Immune Responses Are Driven by Distinct Classes of Immune PotentiatorsElke S Bergmann-Leitner, Wolfgang W Leitner
Methods in Molecular Biology (Clifton, N.J.)|October 10, 2015
Vaccination Using Gene-Gun TechnologyElke S Bergmann-Leitner, Wolfgang W Leitner
Therapeutic Delivery|July 26, 2013
Improving DNA vaccines against malaria: could immunization by gene gun be the answer?Elke S Bergmann-Leitner, Wolfgang W Leitner
Microbes and Infection|April 7, 2004
Danger, death and DNA vaccinesElke S Bergmann-Leitner, Wolfgang W Leitner
Pageof 7